Washington, D.C. (May 12, 2021) — On Wednesday, May 19, 2021, the Select Subcommittee on the Coronavirus Crisis, chaired by Rep. James E. Clyburn, will hold a hybrid in-person / remote hearing with Mr. Robert Kramer, President and Chief Executive Officer of Emergent BioSolutions, Inc. (Emergent), and Mr.
New Evidence Reveals Trump Appointees May Have Directed SBA to Obstruct Congressional Oversight of $750 Million EIDL Contract
Washington, D.C. (April 21, 2021) — Today, Rep. James E.
Select Subcommittee Announces Hearing and Seeks Testimony from Top Emergent Executives
Washington, D.C. (April 19, 2021)—Today, Rep. Carolyn B. Maloney, Chairwoman of the House Committee on Oversight and Reform, and Rep. James E.
Dr. Fauci Cautions That Nation Is at a “Critical Turning Point,” Reaffirms Need to Take Precautions Until Transmission Rates Fall
Washington, D.C. (April 15, 2021) — Today, the Select Subcommittee on the Coronavirus Crisis, chaired by Rep. James E. Clyburn, held a hearing with Centers for Disease Control and Prevention (CDC) Director Rochelle P.
Washington, D.C. (April 15, 2021) —Rep. James E. Clyburn, Chairman of the Select Subcommittee on the Coronavirus Crisis, delivered the following opening statement at today’s hybrid hearing with top Biden Administration health officials:
Report Shows That After Inheriting ‘Multiple Challenges,’ Biden Administration Policies Were Critical to Progress
New Documents Reveal Top Trump Appointee Flaunted Political Interference, Used Personal Email Accounts for Official Business
Washington D.C. (April 9, 2021)—Today, Chairman James E. Clyburn sent letters to three Trump Administration advisors—Dr.